Clots Kill: Hematologic Pharmacology for ST-Segment Elevation Myocardial Infarction
Stacy H. James, RN, MSN, CCRN, ACNP
Clots Kill: Hematologic Pharmacology for ST-Segment Elevation Myocardial Infarction: Read Article
Take Test

Learning Objectives

At the completion of this program, you will be able to:
  • Distinguish between the mechanisms of action of hematologic agents used in the treatment of ST-segment elevation myocardial infarction
  • Differentiate between the pharmacodynamics of 2 classes of antiplatelet agents used in patients experiencing acute coronary syndrome
  • State 3 benefits of giving educational handouts to patients receiving hematologic drugs

Continuing Education Information

CE ID: C1263
Total Contact Hours: 1.00
Pharma Hours: 0.75
Synergy Cat: A
Test Expires: 12/1/2015

Description

Clots Kill: Hematologic Pharmacology for ST-Segment Elevation Myocardial Infarction

Publication/Sponsor Information


Critical Care Nurse is an official publication of the American Association of Critical-Care Nurses (AACN), and copyright belongs to AACN. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or by any information storage retrieval system without permission of AACN. For all permission requests, please contact the Copyright Clearance Center, Customer Service, 222 Rosewood Drive, Danvers, MA 01923. (978) 750-8400. The statements and opinions contained herein are solely those of individual contributors and not of the editors, AACN, or The InnoVision Group. The editors, AACN, and The InnoVision Group assume that articles emanating from a particular institution are submitted with the approval of the requisite authority, including all matters pertaining to human studies and patient privacy requirements.

You have currently started taking the test for . To continue your test in progress, select Return to Test. To abandon this test select Cancel.